Lorazepam Tablet
Product Images NDC 71610-122

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 1 mg (71610 0122 10)

Label for Lorazepam 1 mg oral tablets, containing 10 tablets per package. The label includes the NDC number 71610-0122-10 and indicates the drug is a Schedule IV controlled substance. It provides storage instructions, manufacturer details (Leading Pharma, LLC, Fairfield, NJ), and notes repackaging by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label also states the product is prescription only (RX only).*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Chemical structure of Lorazepam showing the molecular formula C15H10Cl2N2O2 and molecular weight 321.16. The image depicts the arrangement of atoms including chlorine, nitrogen, oxygen, carbon, and hydrogen in the Lorazepam molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.